Personalized Antisense Oligonucleotide Therapy for A Single Participant With CHCHD10 ALS

Clinical trial NCT06392126 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT06392126
Sponsor: n-Lorem Foundation
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Amyotrophic Lateral Sclerosis

Start date: 2024-04-16
Primary completion: 2027-04-01
Enrollment: 1

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.